Raritan, NJ, United States of America

Gaojie Hu

This inventor holds 1 USPTO granted patent. Top assignee: Ethicon, Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gaojie Hu. Retrieved from https://idiyas.com/inventor/gaojie-hu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gaojie Hu and Hemostatic Materials Based on Aldehyde-Functional Polysaccharides.

Introduction

Gaojie Hu is an inventor associated with Raritan, New Jersey, and Ethicon GmbH. His patent work includes a formulation designed to support bleeding control and tissue sealing.

Latest Patents

Hu is credited with 1 patent: “Hemostatic Materials Based on Aldehyde-Functional Polysaccharides.” The invention describes hemostatic and tissue-adhesive formulations containing crosslinked polysaccharide particles oxidized to create aldehyde and carboxylic functional groups. A buffer maintains a slightly alkaline environment, and the formulations can be applied as a powder, paste, or patch to help achieve hemostasis or seal tissue.

Career Highlights

Hu’s listed patent reflects work on biomaterials for medical applications, particularly formulations intended to assist with bleeding control and tissue adhesion. The supplied information associates him with Ethicon GmbH.

Collaborations

Benjamin Fitz is identified as Hu’s coworker. The available information does not specify whether Fitz collaborated on the patent.

Conclusion

Gaojie Hu’s patent describes polysaccharide-based materials intended to support hemostasis and tissue sealing, highlighting his contribution to medical biomaterials innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…